Compare MEDINOVA DIA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MEDINOVA DIAG. vs KRSNAA DIAGNOSTICS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MEDINOVA DIAG. KRSNAA DIAGNOSTICS MEDINOVA DIAG./
KRSNAA DIAGNOSTICS
 
P/E (TTM) x 12.8 - - View Chart
P/BV x - 9.2 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 MEDINOVA DIAG.   KRSNAA DIAGNOSTICS
EQUITY SHARE DATA
    MEDINOVA DIAG.
Mar-21
KRSNAA DIAGNOSTICS
Mar-21
MEDINOVA DIAG./
KRSNAA DIAGNOSTICS
5-Yr Chart
Click to enlarge
High Rs31NA-   
Low Rs11NA-   
Sales per share (Unadj.) Rs12.8998.8 1.3%  
Earnings per share (Unadj.) Rs1.9284.5 0.7%  
Cash flow per share (Unadj.) Rs2.6342.1 0.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %0NM- 
Book value per share (Unadj.) Rs-7.2355.5 -2.0%  
Shares outstanding (eoy) m9.986.50 153.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.70-   
Avg P/E ratio x11.10-  
P/CF ratio (eoy) x8.10-  
Price / Book Value ratio x-2.90-  
Dividend payout %00-   
Avg Mkt Cap Rs m2110-   
No. of employees `000NANA-   
Total wages/salary Rs m17296 5.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1276,492 2.0%  
Other income Rs m1122 1.1%   
Total revenues Rs m1296,615 1.9%   
Gross profit Rs m303,466 0.9%  
Depreciation Rs m7374 1.9%   
Interest Rs m5259 1.8%   
Profit before tax Rs m202,955 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m11,105 0.1%   
Profit after tax Rs m191,849 1.0%  
Gross profit margin %23.653.4 44.2%  
Effective tax rate %2.937.4 7.8%   
Net profit margin %14.928.5 52.5%  
BALANCE SHEET DATA
Current assets Rs m162,481 0.6%   
Current liabilities Rs m801,838 4.3%   
Net working cap to sales %-50.29.9 -506.7%  
Current ratio x0.21.4 14.5%  
Inventory Days Days1925 75.4%  
Debtors Days Days18841 461.8%  
Net fixed assets Rs m253,564 0.7%   
Share capital Rs m1002,489 4.0%   
"Free" reserves Rs m-172-178 96.2%   
Net worth Rs m-722,310 -3.1%   
Long term debt Rs m331,680 1.9%   
Total assets Rs m416,045 0.7%  
Interest coverage x5.212.4 42.3%   
Debt to equity ratio x-0.50.7 -62.6%  
Sales to assets ratio x3.11.1 290.9%   
Return on assets %58.034.9 166.4%  
Return on equity %-26.580.0 -33.1%  
Return on capital %-61.880.5 -76.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m191,026 1.9%  
From Investments Rs m-3-611 0.5%  
From Financial Activity Rs m-14308 -4.5%  
Net Cashflow Rs m2723 0.3%  

Share Holding

Indian Promoters % 62.1 27.4 227.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 34.6 -  
FIIs % 0.0 4.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 37.9 72.6 52.1%  
Shareholders   9,906 75,065 13.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MEDINOVA DIAG. With:   FORTIS HEALTHCARE    INDRAPRASTHA MEDICAL    THYROCARE TECHNOLOGIES    DR. LAL PATHLABS    KOVAI MEDICAL    



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

ITC to Coal India: Are these the Best Dividend Stocks You can Count on? (Views On News)

Jan 25, 2022

A list of companies that have paid dividends regularly for years, creating value for shareholders.

JLR, Corus, Tetley - Was Ratan Tata's Go Global Strategy Right Afterall? (Views On News)

Jan 20, 2022

Ratan Tata took the lead in global acquisitions and changed the mindset of India's business leaders. Was he successful after all?

Top 4 Oxygen Stocks to Add to Your Watchlist (Views On News)

Jan 12, 2022

Amid a surge in Covid cases, states have been asked to keep adequate stock of medical oxygen for at least 48 hours.

Omicron: Sectors to Buy and Avoid in 2022 (Views On News)

Jan 11, 2022

We take a look at how stocks of 6 major sectors were impacted, the last time lockdowns were imposed and what we can learn from it.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MEDINOVA DIAG. SHARE PRICE


Jan 25, 2022 (Close)

TRACK MEDINOVA DIAG.

  • Track your investment in MEDINOVA DIAG. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MEDINOVA DIAG.

MEDINOVA DIAG. - KAYA COMPARISON

COMPARE MEDINOVA DIAG. WITH

MARKET STATS